Ken Griffin Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $7.42 Million - $7.79 Million	-51,157 Reduced 21.61%	185,618 $28.1 Million
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $7.55 Million - $13.3 Million	90,863 Added 62.27%	236,775 $34.5 Million
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $11.6 Million - $15 Million	105,146 Added 257.93%	145,912 $17.3 Million
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $12.2 Million - $18.1 Million	-122,215 Reduced 74.99%	40,766 $5.62 Million
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $12.7 Million - $17.9 Million	128,607 Added 374.14%	162,981 $22.6 Million
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $628,067 - $1 Million	-9,548 Reduced 21.74%	34,374 $3.34 Million
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $5.22 Million - $7.48 Million	-81,517 Reduced 64.99%	43,922 $3 Million
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $4.94 Million - $7.46 Million	75,892 Added 153.17%	125,439 $10.8 Million
Q3 2020 Nov 16, 2020	SELL	$59.04 - $77.95 $14.7 Million - $19.4 Million	-248,772 Reduced 83.39%	49,547 $3.22 Million
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $2.43 Million - $6.21 Million	83,694 Added 39.0%	298,319 $21.8 Million
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $2.02 Million - $4.21 Million	-73,472 Reduced 25.5%	214,625 $7.3 Million
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $27.4 Million - $38.7 Million	-670,968 Reduced 69.96%	288,097 $15.7 Million
Q3 2019 Nov 14, 2019	SELL	$37.38 - $49.47 $12.5 Million - $16.5 Million	-333,437 Reduced 25.8%	959,065 $40 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $23.6 Million - $39.8 Million	593,727 Added 84.97%	1,292,502 $56.6 Million
Q1 2019 May 15, 2019	SELL	$34.52 - $53.29 $8.27 Million - $12.8 Million	-239,464 Reduced 25.52%	698,775 $0
Q4 2018 Feb 14, 2019	SELL	$29.75 - $42.9 $1.26 Million - $1.82 Million	-42,508 Reduced 4.33%	938,239 $34.7 Million
Q3 2018 Nov 13, 2018	BUY	$32.79 - $43.0 $4.25 Million - $5.58 Million	129,697 Added 15.24%	980,747 $0
Q2 2018 Aug 10, 2018	BUY	$23.62 - $42.29 $9.71 Million - $17.4 Million	411,017 Added 93.41%	851,050 $0
Q1 2018 May 11, 2018	BUY	$22.49 - $34.56 $4.03 Million - $6.19 Million	179,024 Added 68.59%	440,033 $11.3 Million
Q4 2017 Feb 09, 2018	BUY	$20.44 - $35.56 $1.17 Million - $2.04 Million	57,307 Added 28.13%	261,009 $7.04 Million
Q3 2017 Nov 09, 2017	BUY	$23.54 - $38.21 $4.8 Million - $7.78 Million	203,702	203,702 $7.61 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account